+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06714097

Evaluating the STRATIF-AI Digital Twin Platform for Secondary Prevention in Stroke, Moyamoya Disease, and Cerebral Amyloid Angiopathy A Randomized Controlled Proof-of-Concept Study

Led by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Updated on 2026-08-28

20

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate the use of the STRATIF-AI platform and digital twin technology during the secondary prevention phase in adults with stroke, Moyamoya disease, and Cerebral Amyloid Angiopathy CAA. The study compares patients using the STRATIF-AI app alongside standard secondary prevention to those receiving standard secondary prevention alone. Researchers want to understand patients experiences and the usability of the STRATIF-AI platform. Participants are randomly assigned to one of two groups. One group uses the STRATIF-AI app daily to manage their health and may connect wearable devices to the app, while also following standard secondary prevention care. The other group receives only the usual secondary prevention treatments and monitoring. Cognitive and psychological assessments are conducted at the start and after six months for all participants. The group using the app will also participate in interviews to share their feedback about the app. During the study, participants undergo evaluations including cognitive tests like the Montreal Cognitive Assessment MOCA, health and disability surveys, and psychological scales. Researchers collect clinical and socio-demographic data, as well as details about their medical history and current therapies. The study gathers both quantitative data from these assessments and qualitative feedback from interviews to analyze the user experience with the digital twin technology. The total study period includes baseline and six-month follow-up assessments.

CONDITIONS

Brief Title

Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project)

Research Team

M

Matilde Leonardi, MD

B

Barbara Maistrello

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here